Award
National Institute of Allergy and Infectious Diseases 5R01AI078908-16
Control of Pulmonary Inflammation by Leukotriene E4
Recipient
Brigham and Women's Hospital
Award Amount
$700,679.00
Ceiling
$700,679.00
Awarded
July 31, 2025
Identifier
5R01AI078908-16
Research project funded by NIAID to study the role of leukotriene E4 in airway inflammation and asthma, aiming to develop new therapies.
Description
This project will determine mechanisms by which cysteinyl leukotrienes facilitate airway inflammation and airway dysfunction that underlies asthma. The results of the studies should yield information that can be used to generate new therapies, and will also improve our understanding of the causes of asthma.